Earlier this year., India's Drugs Controller General granted permission to Pune Maharashtra-based Serum Institute of India to supply over 32,000 doses of its COVID-19 jab Covovax under the brand name Nuvaxovid to the U.S. Covovax is manufactured through technology transfer from Novavax, an American Company and is approved by the...
India’s Serum Institute Manufactures Vaccines for U.S. Government
Following on an approval from the USFDA, Gaithersburg, Maryland-based biotechnology company Novavax said that its Covid-19 vaccine Nuvaxovid for adults will be manufactured by its partner Serum Institute of India. (SII) "It is the first vaccine from India to be approved by the USFDA," Serum Institute’s CEO Adar Poonawalla, said....